Source - RNS
RNS Number : 8429K
AstraZeneca PLC
26 September 2016
 

26 September 2016 16:00

 

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

 

On 26 September 2016, the interest of Sean Bohen, a person discharging managerial responsibilities, in the ordinary shares of AstraZeneca PLC changed as detailed below.

 

The change in interest relates to the vesting of an award of AstraZeneca American Depositary Shares (ADSs) made in September 2015 under the AstraZeneca Restricted Share Plan.

 

One ordinary share equals two ADSs.

 

After sufficient vested shares were withheld to satisfy certain tax obligations arising on the vesting, Mr Bohen has become beneficially entitled to and has received 12,385 ADSs into a personal brokerage account.

 

For tax purposes, the fair market value of the shares at vest was $33.97 per ADS being the closing price on the last trading day preceding the vesting day.

 

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Sean Bohen

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Vice-President, Global Medicines Development and Chief Medical Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

AstraZeneca PLC

b)

 

LEI

 

Not applicable

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

AstraZeneca PLC American Depositary Shares

 

 

 

CUSIP: 046353108

 

b)

 

Nature of the transaction

 

 

Acquisition of AstraZeneca American Depositary Shares pursuant to the vesting of an award under the AstraZeneca Restricted Share Plan

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

$33.97

12,385

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

Not applicable - single transaction

 

 

 

 

 

e)

 

Date of the transaction

 

26 September 2016

f)

 

Place of the transaction

 

New York

 

 

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com    

 

CONTACTS

 

Media Enquiries

 

 

 

 

 

Neil Burrows

 

UK/Global

 

+44 203 749 5637

 

Vanessa Rhodes

 

UK/Global

 

+44 203 749 5736

 

Karen Birmingham

 

UK/Global

 

+44 203 749 5634

 

Rob Skelding

 

UK/Global

 

+44 203 749 5821

 

Jacob Lund

 

Sweden

 

+46 8 553 260 20

 

Michele Meixell

 

US

 

+1 302 885 2677

 

Investor Relations



UK



Thomas Kudsk Larsen

 

 

 

+44 203 749 5712

 

Craig Marks

 

Finance, Fixed Income, M&A

 

+44 7881 615 764

 

Nick Stone

 

Respiratory & Autoimmunity

 

+44 203 749 5716

 

Henry Wheeler

 

Oncology

 

+44 203 749 5797

 

Christer Gruvris

Infection & Neuroscience

+44 203 749 5711

US



Lindsey Trickett

 

Cardiovascular & Metabolic Diseases

 

+1 240 543 7970

 

Mitchell Chan

 

 Oncology

 

+1 240 477 3771

 

Toll-free


+1 866 381 7277

 

Adrian Kemp

Company Secretary

AstraZeneca PLC

 

-ENDS-

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUNUORNOAKUAR

Related Charts

AstraZeneca (AZN)

-25.50p (-0.63%)
delayed 18:15PM